Back
Verrica Pharmaceuticals Vs. Adobe Industry Stock Comparison
Sell
14
VRCA
Verrica Pharmaceuticals
Last Price:
$0.56
Seasonality Move:
-3.06%
Sell
44
ADBE
Adobe
Last Price:
$387.18
Seasonality Move:
10.94%
Sell
14
Verrica Pharmaceuticals (VRCA)
is a Sell
Is Verrica Pharmaceuticals a Buy, Sell or Hold?
-
The current Verrica Pharmaceuticals [VRCA] share price is $0.56. The Score for VRCA is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
-
VRCA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
44
Adobe (ADBE)
is a Sell
Is Adobe a Buy, Sell or Hold?
-
ADBE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VRCA Stock Price Chart
What is Verrica Pharmaceuticals's stock price today?
-
The Verrica Pharmaceuticals share price today is $0.56Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRCA is experiencing selling pressure, which indicates risk of future bearish movement.
ADBE Stock Price Chart
VRCA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 39.75 | Sell |
Chaikin Money Flow: | -2478071 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.59 - 0.71) | Sell |
Bollinger Bands (100): | (0.56 - 1.1) | Sell |
ADBE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -15.52 | Sell |
Relative Strength Index (14 RSI): | 32.47 | Sell |
Chaikin Money Flow: | 2253104 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (404.23 - 459.41) | Sell |
Bollinger Bands (100): | (420.97 - 502.61) | Sell |
VRCA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.6 | Sell |
20-day SMA: | 0.63 | Sell |
50-day SMA: | 0.67 | Sell |
200-day SMA: | 2.8 | Sell |
8-day EMA: | 0.61 | Sell |
20-day EMA: | 0.63 | Sell |
50-day EMA: | 0.71 | Sell |
200-day EMA: | 2.23 | Sell |
ADBE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 395.83 | Sell |
20-day SMA: | 424.61 | Sell |
50-day SMA: | 432.36 | Sell |
200-day SMA: | 495.44 | Sell |
8-day EMA: | 398.68 | Sell |
20-day EMA: | 416.88 | Sell |
50-day EMA: | 435.62 | Sell |
200-day EMA: | 479.83 | Sell |
Verrica Pharmaceuticals Earnings Growth & VRCA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.94 per share, and an increase next year of $0.16 per share.
Adobe Earnings Growth & ADBE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.58 per share, an increase next quarter of $0.49 per share, an increase this year of $2.14 per share, and an increase next year of $2.49 per share.
Verrica Pharmaceuticals Technical Analysis
Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Adobe Technical Analysis
Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |